Efficacy of ezetimibe for the treatment of non-alcoholic steatohepatitis: An open-label, pilot study
{{output}}
Aim: Non-alcoholic steatohepatitis (NASH) is considered a hepatic manifestation of metabolic syndrome. However, effective drug therapy for NASH has not been established yet. In the present study, we evaluated the efficacy of 6 mo... ...
